ZA975889B - HIV envelope polypeptides and vaccine. - Google Patents

HIV envelope polypeptides and vaccine.

Info

Publication number
ZA975889B
ZA975889B ZA9705889A ZA975889A ZA975889B ZA 975889 B ZA975889 B ZA 975889B ZA 9705889 A ZA9705889 A ZA 9705889A ZA 975889 A ZA975889 A ZA 975889A ZA 975889 B ZA975889 B ZA 975889B
Authority
ZA
South Africa
Prior art keywords
vaccine
hiv envelope
envelope polypeptides
polypeptides
hiv
Prior art date
Application number
ZA9705889A
Other languages
English (en)
Inventor
Phillip W Berman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA975889B publication Critical patent/ZA975889B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9705889A 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine. ZA975889B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67673796A 1996-07-08 1996-07-08

Publications (1)

Publication Number Publication Date
ZA975889B true ZA975889B (en) 1998-02-23

Family

ID=24715764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705889A ZA975889B (en) 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine.

Country Status (13)

Country Link
US (1) US6090392A (da)
EP (1) EP0942988A1 (da)
JP (1) JP2000515368A (da)
AP (1) AP1282A (da)
AU (1) AU727107B2 (da)
CA (1) CA2259965A1 (da)
ID (1) ID17767A (da)
IL (2) IL127701A0 (da)
NZ (1) NZ333500A (da)
OA (1) OA10954A (da)
TW (1) TWI221846B (da)
WO (1) WO1998001564A1 (da)
ZA (1) ZA975889B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2903999A (en) * 1998-03-12 1999-09-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
MXPA02007478A (es) 2000-02-04 2004-08-23 Univ Duke Vacuna contra el virus de inmunodeficiencia humana.
WO2001083535A2 (en) * 2000-05-02 2001-11-08 Simon Fraser University Polypeptides for use as a vaccine and/or treatment for hiv infection
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
US7754676B2 (en) 2000-09-15 2010-07-13 The United States Of America As Represented By The Department Of Health And Human Services Defensin-antigen fusion proteins
US7897152B2 (en) 2000-09-18 2011-03-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Viral chemokine-antigen fusion proteins
US20060116325A1 (en) * 2001-02-15 2006-06-01 Oleg Chertov Methods and compositions for inhibiting hiv-coreceptor interactions
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
CA2505583C (en) * 2002-12-03 2014-07-15 University Of Massachusetts Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
MXPA05013334A (es) * 2003-06-12 2006-05-19 Vexgen Inc Glucoproteinas de envoltura de vih-1 que tienen estructuras de disulfuro inusuales.
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
WO2005040816A1 (en) 2003-10-24 2005-05-06 Immunaid Pty Ltd Method of therapy
JP5386083B2 (ja) * 2004-09-08 2014-01-15 イミューンネイド ピーティーワイ リミテッド 自己免疫疾患および変性疾患を治療する方法
WO2006031870A2 (en) * 2004-09-14 2006-03-23 Argos Therapeutics, Inc. Strain independent amplification of pathogens and vaccines thereto
CN101313216A (zh) * 2005-09-22 2008-11-26 普洛茨股份有限公司 酵母突变体中产生的糖基化多肽及其使用方法
WO2009017743A2 (en) * 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
HUE026456T2 (en) 2009-05-27 2016-05-30 Biotempus Ltd Methods of treating diseases
EP2451950B9 (en) 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Methods for preparing vesicles and formulations produced therefrom
WO2011005772A1 (en) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
BR112013000394B8 (pt) 2010-07-06 2022-01-18 Variation Biotechnologies Inc Composição imunogênica, uso da mesma e método para preparar a referida composição
EP2663327A4 (en) 2011-01-13 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
EP4008354A1 (en) 2012-01-27 2022-06-08 Variation Biotechnologies Inc. Methods and compositions for therapeutic agents
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2928924A4 (en) 2012-12-04 2016-07-13 Univ Maryland HIV-1 ENV BINDING ANTIBODIES, FUSION PROTEINS AND METHODS OF USE
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
EP0279688B1 (en) * 1987-02-20 1997-04-16 Genentech, Inc. Methods and compositions for the use of HIV env polypeptides and antibodies thereto
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
EP0493508A1 (en) * 1989-09-22 1992-07-08 Idec Pharmaceuticals Corporation Novel peptides associated with the cd4 binding region of gp120 and their methods of use
DK0527760T3 (da) * 1990-04-03 1995-11-27 Genentech Inc Fremgangsmåder og præparater til vaccination mod HIV
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
CA2164505A1 (en) * 1993-06-07 1994-12-22 Phillip W. Berman Hiv envelope polypeptides

Also Published As

Publication number Publication date
CA2259965A1 (en) 1998-01-15
JP2000515368A (ja) 2000-11-21
OA10954A (en) 2001-10-25
US6090392A (en) 2000-07-18
NZ333500A (en) 2000-09-29
AU3567797A (en) 1998-02-02
TWI221846B (en) 2004-10-11
IL127701A (en) 2006-08-01
AU727107B2 (en) 2000-11-30
ID17767A (id) 1998-01-22
AP9901432A0 (en) 1999-03-31
WO1998001564A1 (en) 1998-01-15
AP1282A (en) 2004-06-09
IL127701A0 (en) 1999-10-28
EP0942988A1 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
ZA975889B (en) HIV envelope polypeptides and vaccine.
EP0708659A4 (en) HIV ENVELOPE POLYPEPTIDES
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
CZ20011341A3 (cs) Pomocné přípravky a vakciny
EP0611168A3 (en) Hop extract and its use.
CY2433B1 (en) Interferon conjugates.
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
ZA972727B (en) A novel composition, its preparation and use.
ZA975533B (en) Cyclosporin-containing pharmaceutical composition.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
PL331765A1 (en) Trnsplant prosthesis, materials and methods
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
ZA976815B (en) Vaccine composition.
ZA975034B (en) Airship.
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
HUP9701586A3 (en) Improved inactivated vaccines
ZA9711565B (en) Vaccine
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
GB2331521B (en) Vaccine preparations
EP0586154A3 (en) Melanin-inhibiting protein, its production and applications.
GB9704977D0 (en) FIV vaccine
ZA9610510B (en) Novel peptides, the preparation and use thereof.